封面
市场调查报告书
商品编码
1561046

细胞培养基市场规模、份额、成长分析,按类型、按应用、按最终用户、按地区 - 行业预测,2024-2031 年

Cell Culture Media Market Size, Share, Growth Analysis, By Type, By Application, By End User, By Region - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 213 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2022年细胞培养基的全球市场规模为52亿美元,从2023年的62.3亿美元成长到2031年的204.5亿美元,在预测期间(2024-2031)预计复合年增长率为16.02% 。

由于新传染病的增加,预计该市场将继续成长。製药和生物技术公司是细胞培养基的主要用户,因为它们支持新型创新疫苗的开发。该技术解决了与动物测试相关的伦理问题,并为传统的动物疫苗测试提供了可行的替代方案。细胞培养基消除了研究过程中动物牺牲的需要,提供了更人性化的解决方案。

目录

介绍

  • 研究目的
  • 定义
  • 市场范围

调查方法

  • 资讯采购
  • 二手资料来源和主要资料来源
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 市场概况展望
  • 供需趋势分析
  • 按细分市场的机会分析

市场动态及展望

  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务
  • 波特的分析

主要市场考察

  • 关键成功因素
  • 竞争程度
  • 主要投资机会
  • 市场生态系统
  • 专利分析
  • 价值链分析
  • 供应链分析
  • 价格分析
  • 贸易分析
  • 监管环境
  • 客户和购买标准分析

细胞培养基市场:依类型

  • 无血清培养基
    • CHO培养基
    • HEK 293 介质
    • BHK培养基
    • VERO细胞培养基
    • 无血清干细胞培养基
    • 免疫细胞培养基
    • 昆虫细胞培养基
    • 其他无血清培养基
  • 常规介质和盐
  • 干细胞培养基
  • 化学成分确定的 (CD) 介质
  • 专门的培养基
  • 其他细胞培养基

细胞培养基市场:依应用分类

  • 市场概况
  • 生物製药製造
    • 单株抗体生产
    • 疫苗生产
    • 其他治疗性蛋白质製造应用
  • 诊断
  • 组织工程与再生医学
    • 细胞/基因治疗
    • 其他组织工程及再生医学应用
  • 药物筛检与开发
  • 其他用途

细胞培养基市场:依最终用户分类

  • 市场概况
  • 製药和生物技术公司
  • 医院和诊断实验室
  • 研究/学术机构
  • 其他最终用户

细胞培养基市场规模:按地区

  • 市场概况
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲 (MEA)
    • 海湾合作委员会国家
    • 南非
    • 其他中东/非洲地区

竞争格局

  • 前5名企业对比
  • 主要企业市场定位(2023年)
  • 主要市场参与者所采取的策略
  • 近期市集活动
  • 主要企业市场占有率(2023年)

主要企业简介

  • Thermo Fischer Scientific
  • Merck KGAA
  • Danaher
  • Sartorius AG
  • Corning Incorporated
  • Fujifilm Holdings Corporation
  • Lonza
  • Becton, Dickinson And Company(BD)
  • Stemcell Technologies
  • Miltenyi Biotec
  • Himedia Laboratories
  • Biologos
  • Promocell Gmbh
  • Invivogen
  • Pan-Biotech
  • Cellular Technology Limited
  • Cyagen Biosciences
  • Biowest
  • Akron Biotech
  • Kcell Biosciences
简介目录
Product Code: SQMIG35H2057

Global Cell Culture Media Market size was valued at USD 5.2 billion in 2022 and is poised to grow from USD 6.23 billion in 2023 to USD 20.45 billion by 2031, growing at a CAGR of 16.02% during the forecast period (2024-2031).

The market is projected to grow in the future due to the rise of new communicable diseases. Pharmaceutical and biotechnology companies are significant users of cell culture media, as it supports the development of new and innovative vaccines. This technology provides a viable alternative to traditional vaccine trials conducted on animals, addressing ethical concerns associated with animal testing. Cell culture media offers a more humane solution by eliminating the need for animal sacrifice in the research process.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Culture Media market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Culture Media Market Segmental Analysis

Global Cell Culture Media Market is segmented by Type, Application, End User and Region. Based on Type , the market is segmented into Serum-Free Media (CHO Media, HEK 293 Media, BHK Media, VERO Cell Media, Serum-Free Stem Cell Media, Immune Cell Media, Insect Cell Media, Other Serum-Free Media), Classical Media & Salts, Stem Cell Culture Media, Chemically Defined (CD) Media, Specialty Media, Other Cell Culture Media. Based on Application, the market is segmented into Biopharmaceutical Production (Monoclonal Antibody Production, Vaccine Production, Other Therapeutic Protein Production Applications), Diagnostics, Tissue Engineering & Regenerative Medicine (Cell & Gene Therapy, Other Tissue Engineering & Regenerative Medicine Applications), Drug Screening & Development, Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Research & Academic Institutes, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Drivers of the Global Cell Culture Media Market

The recent pandemic has accelerated market growth significantly. Cell culture media have become crucial for producing and testing new vaccines and medicines. Over the past few years, the expansion of biotechnology and pharmaceutical companies has driven increased demand for cell culture media, which are essential for developing innovative vaccines and medicines. The rise in stringent safety regulations for vaccines and efforts to curb the spread of communicable diseases have led researchers to increasingly rely on cell culture media for testing and trials.

Restraints in the Global Cell Culture Media Market

Cell culture media predominantly uses plastic materials, which accumulate over time and contribute to significant waste. Plastics are not easily degradable and, when incinerated, release harmful gases. Many countries are imposing bans on plastics due to their environmental impact. Since these plastics are intended for single use only, they cannot be reused or recycled. The rising regulatory standards for cell culture media are further driving up product costs at an accelerated pace.

Market Trends of the Global Cell Culture Media Market

Regenerative medicine represents an innovative and rapidly growing field focused on developing therapies to replace or repair damaged tissues and organ systems within the human body. This field leverages a combination of cells, biomaterials, and molecules to restore bodily structures affected by injury or disease. As these therapies depend on specialized cell culture media to support their development and application, the increasing demand for regenerative medicine is anticipated to significantly drive the growth of the cell culture media market.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Ecosystem of the Market
  • Patent Analysis
  • Value Chain Analysis
  • Supply Chain Analysis
  • Pricing Analysis
  • Trade Analysis
  • Regulatory Landscape
  • Customer & Buying Criteria Analysis

Cell Culture Media Market, By Type

  • Serum-Free Media
    • CHO Media
    • HEK 293 Media
    • BHK Media
    • VERO Cell Media
    • Serum-Free Stem Cell Media
    • Immune Cell Media
    • Insect Cell Media
    • Other Serum-Free Media
  • Classical Media & Salts
  • Stem Cell Culture Media
  • Chemically Defined (CD) Media
  • Specialty Media
  • Other Cell Culture Media

Cell Culture Media Market, By Application

  • Market Overview
  • Biopharmaceutical Production
    • Monoclonal Antibody Production
    • Vaccine Production
    • Other Therapeutic Protein Production Applications
  • Diagnostics
  • Tissue Engineering & Regenerative Medicine
    • Cell & Gene Therapy
    • Other Tissue Engineering & Regenerative Medicine Applications
  • Drug Screening & Development
  • Other Applications

Cell Culture Media Market, By End User

  • Market Overview
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Laboratories
  • Research & Academic Institutes
  • Other End Users

Cell Culture Media Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Thermo Fischer Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGAA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sartorius AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Corning Incorporated
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fujifilm Holdings Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lonza
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson And Company (BD)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stemcell Technologies
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Miltenyi Biotec
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Himedia Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biologos
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Promocell Gmbh
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Invivogen
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pan-Biotech
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cellular Technology Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cyagen Biosciences
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biowest
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Akron Biotech
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kcell Biosciences
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments